Data / Form D filings / QurAlis Corp
QurAlis Corp: Form D filings
QurAlis Corp, a pharmaceuticals company in Cambridge, MA, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on September 5, 2025, reports $20 million sold of a $24.9 million offering to 19 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 35 CAMBRIDGE PARK DRIVE, Cambridge, MA, 02140
- Phone
- (781) 816-7031
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1811817
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | New notice | $24,921,734 | $19,952,387 | $4,969,347 | 19 | Aug 21, 2025 | sec.gov |
| Mar 13, 2023 | New notice | $88,019,211 | $59,982,508 | $28,036,703 | 27 | Dec 20, 2022 | sec.gov |
| Sep 1, 2022 | New notice | $10,000,000 | $5,000,000 | $5,000,000 | 19 | Aug 12, 2022 | sec.gov |
| May 18, 2020 | New notice | $60,000,000 | $33,222,703 | $26,777,297 | 25 | May 1, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Laia C.D. Crespo-Martin | Director | |
| Shafique C.D. Virani | Executive Officer | |
| Johannes C.D. Fruehauf | Director | |
| Michael C.D. Hutton | Director | |
| Jason C.D. Brown | Executive Officer | |
| Anne C.D. Whitaker | Director | |
| Kasper C.D. Roet | Director, Executive Officer, Promoter | |
| Kasper C.D. Roet | Director, Executive Officer, Promoter | |
| Amy C.D. Schulman | Director | |
| Luc C.D. Dochez | Director | |
| Cillian C.D. King | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Sep 1, 2025 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what QurAlis Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.